You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sustained Release Growth Hormone

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • AR-14034 SR implant lower dose
  • +3 more
  • (no location specified)
Mar 3, 2023

A Prospective, Non-interventional, Long-term, Post-Authorisation

Not yet recruiting
  • Growth Hormone Deficiency
  • No intervention
  • (no location specified)
Mar 8, 2023

Metastatic Prostate Cancer Trial in Guangzhou (Metformin)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jun 8, 2021

Adult Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency Trial in Las Vegas (Lonapegsomatropin)

Recruiting
  • Adult Growth Hormone Deficiency
  • +2 more
  • Las Vegas, Nevada
    Ascendis Pharma Investigational Site
Dec 28, 2021

Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (Lonapegsomatropin, Placebo,

Recruiting
  • Growth Hormone Deficiency
  • +2 more
  • Phoenix, Arizona
  • +63 more
Apr 12, 2022

Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)

Completed
Has Results
  • Growth Hormone Deficiency, Pediatric
  • +3 more
  • TransCon hGH
  • Birmingham, Alabama
  • +23 more
Dec 7, 2021

Growth Hormone Deficiency, Pediatric, hGH (Human Growth Hormone), Endocrine System Diseases Trial in Worldwide (Once weekly

Completed
Has Results
  • Growth Hormone Deficiency, Pediatric
  • +4 more
  • Once weekly subcutaneous injection of TransCon hGH
  • Once daily subcutaneous injection of Genotropin
  • Birmingham, Alabama
  • +52 more
Dec 6, 2021

Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)

Active, not recruiting
  • Growth Hormone Deficiency, Pediatric
  • +3 more
  • TransCon hGH
  • Birmingham, Alabama
  • +41 more
Oct 13, 2021

Eating Disorder, Bulimia Nervosa Trial (Acipimox, Placebo)

Enrolling by invitation
  • Eating Disorder
  • Bulimia Nervosa
  • (no location specified)
Jul 19, 2022

Fertility Disorders, Hypothalamic Dysfunction Trial in London (Kisspeptin 0.1, Saline, Kisspeptin 0.3)

Recruiting
  • Fertility Disorders
  • Hypothalamic Dysfunction
  • Kisspeptin 0.1
  • +3 more
  • London, United Kingdom
    Imperial College NHS Healthcare Trust
Jan 24, 2023

Diabetic Macular Edema Trial (OXU-001, Semi-automated suprachoroidal illuminated microcatheter, Ozurdex® Ophthalmic Intravitreal

Not yet recruiting
  • Diabetic Macular Edema
  • (no location specified)
Jan 24, 2023

Markers of Metabolism and Vascular Access in ESRD

Not yet recruiting
  • Disorders of Calcium and Bone Metabolism
  • vascular acess
  • (no location specified)
May 2, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in United States (AR-13503 Implant 10.6 Dose,

Completed
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • AR-13503 Implant 10.6 Dose
  • +3 more
  • Gilbert, Arizona
  • +5 more
Jun 9, 2022

Growth Hormone Deficiency Trial in Santiago (LUM-201)

Recruiting
  • Growth Hormone Deficiency
  • Santiago, Chile
    Institute of Maternal and Child Research, University of Chile
Jul 12, 2022

Discontinuation in Adults on Metabolic Profile, Body Composition

Recruiting
  • Adult Growth Hormone Deficiency
  • Dual energy X-ray absorptiometry (DXA)
  • Birmingham, West Midlands, United Kingdom
    University Hospitals Birmingham NHS Foundation Trust
Jul 28, 2023

Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets

Active, not recruiting
  • Partial Seizure
  • Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Municipal People's Hospital
Jan 31, 2023

Lipodystrophy, HIV Trial in Worldwide (Tesamorelin, Placebo for Tesamorelin)

Completed
Has Results
  • Lipodystrophy
  • HIV Infections
  • Birmingham, Alabama
  • +46 more
Sep 16, 2022

Oxycodone Sustained-release Tablets for Moderate to Severe

Recruiting
  • Cancer Pain
  • +2 more
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jul 24, 2023

    Proximal Muscle Strength, Proximal Muscle Lengthening Trial in Memphis (myofascial release, blood flow restriction)

    Not yet recruiting
    • Proximal Muscle Strength
    • Proximal Muscle Lengthening
    • myofascial release
    • blood flow restriction
    • Memphis, Tennessee
      University of Tennessee Health Science Center
    Jan 24, 2023

    Neuropathic Pain, Diabetes, Type 2 Trial in Korea, Republic of (pregabalin sustained release tablet, pregabalin immediate

    Active, not recruiting
    • Neuropathic Pain
    • Diabetes Mellitus, Type 2
    • pregabalin sustained release tablet
    • pregabalin immediate release capsule
    • Cheongju, Chungcheongbuk-do, Korea, Republic of
    • +7 more
    Nov 14, 2022

    Cerebral Small Vessel Diseases Trial in Beijing (Pentoxifylline sustained-release tablets, Pentoxifylline sustained-release

    Not yet recruiting
    • Cerebral Small Vessel Diseases
    • Pentoxifylline sustained-release tablets
    • Pentoxifylline sustained-release tablets placebo
    • Beijing, China
      Beijing Tiantan Hospital
    Oct 13, 2022

    Generalized Anxiety Disorder Trial in Beijing (Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg,

    Not yet recruiting
    • Generalized Anxiety Disorder
    • Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg
    • +2 more
    • Beijing, China
      Peking University Sixth Hospital
    Aug 1, 2023

    Crohn's Disease, Oral Ulcer Trial in Xi'an (Mesalazine Sustained-Release Tablets, Riboflavin Sodium Phosphate Injection)

    Withdrawn
    • Crohn's Disease
    • Oral Ulcer
    • Mesalazine Sustained-Release Tablets
    • Riboflavin Sodium Phosphate Injection
    • Xi'an, Shaanxi, China
      Xijing Hospital
    Jan 30, 2023

    Somatic Symptom Trial in Shanghai (toludesvenlafaxine HCl sustained-release tablets)

    Not yet recruiting
    • Somatic Symptom
    • toludesvenlafaxine hydrochloride sustained-release tablets
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center
    May 6, 2023

    Sarpogrelate, Blood Viscosity, Peripheral Arterial Disease Trial in Uijeongbu (Sarpogrelate Sustained Release/Aspirin, Aspirin)

    Recruiting
    • Sarpogrelate
    • +3 more
    • Sarpogrelate Sustained Release/Aspirin
    • Aspirin
    • Uijeongbu, Gyeonggi-do, Korea, Republic of
      The Catholic University of Korea Uijeongbu St. Mary's Hospital
    Feb 6, 2023